Evaluation of the clinical value of 10 estimating glomerular filtration rate equations and construction of a prediction model for kidney damage in adults from central China

评价10种估算肾小球滤过率方程的临床价值,并构建中国中部地区成年人肾损伤预测模型

阅读:1

Abstract

OBJECTIVES: This study aimed to evaluate 10 estimating glomerular filtration rate (eGFR) equations in central China population and construct a diagnostic prediction model for assessing the kidney damage severity. METHODS: The concordance of 10 eGFR equations was investigated in healthy individuals from central China, and their clinical effectiveness in diagnosing kidney injury was evaluated. Subsequently, relevant clinical indicators were selected to develop a clinical prediction model for kidney damage. RESULTS: The overall concordance between CKD-EPI(ASR-Scr) and CKD-EPI(2021-Scr) was the highest (weightedκ = 0.964) in healthy population. The CG formula, CKD-EPI(ASR-Scr) and CKD-EPI(2021-Scr) performed better than others in terms of concordance with referenced GFR (rGFR), but had poor ability to distinguish between rGFR < 90 or < 60 mL/min·1.73 m(2). This finding was basically consistent across subgroups. Finally, two logistic regression prediction models were constructed based on rGFR < 90 or 60 mL/min·1.73 m(2). The area under the curve of receiver operating characteristic values of two prediction models were 0.811 vs 0.846 in training set and 0.812 vs 0.800 in testing set. CONCLUSION: The concordance of CKD-EPI(ASR-Scr) and CKD-EPI(2021-Scr) was the highest in the central China population. The Cockcroft-Gault formula, CKD-EPI(ASR-Scr), and CKD-EPI(2021-Scr) more accurately reflected true kidney function, while performed poorly in the staging diagnosis of CKD. The diagnostic prediction models showed the good clinical application performance in identifying mild or moderate kidney injury. These findings lay a solid foundation for future research on renal function assessment and predictive equations.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。